|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pliarchopoulou K and Pectasides D:
Epithelial ovarian cancer: Focus on targeted therapy. Crit Rev
Oncol Hematol. 79:17–23. 2011. View Article : Google Scholar
|
|
3
|
Schummer M, Ng WV, Bumgarner RE, Nelson
PS, Schummer B, Bednarski DW, Hassell L, Baldwin RL, Karlan BY and
Hood L: Comparative hybridization of an array of 21,500 ovarian
cDNAs for the discovery of genes overexpressed in ovarian
carcinomas. Gene. 238:375–385. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cornwall GA, von Horsten HH, Swartz D,
Johnson S, Chau K and Whelly S: Extracellular quality control in
the epididymis. Asian J Androl. 9:500–507. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Karlsen MA, Høgdall EV, Christensen IJ,
Borgfeldt C, Kalapotharakos G, Zdrazilova-Dubska L, Chovanec J, Lok
CA, Stiekema A, Mutz-Dehbalaie I, et al: A novel diagnostic index
combining HE4, CA125 and age may improve triage of women with
suspected ovarian cancer - An international multicenter study in
women with an ovarian mass. Gynecol Oncol. 138:640–646. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Romagnolo C, Leon AE, Fabricio AS,
Taborelli M, Polesel J, Del Pup L, Steffan A, Cervo S, Ravaggi A,
Zanotti L, et al: HE4, CA125 and risk of ovarian malignancy
algorithm (ROMA) as diagnostic tools for ovarian cancer in patients
with a pelvic mass: An Italian multicenter study. Gynecol Oncol.
141:303–311. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wilailak S, Chan KK, Chen CA, Nam JH,
Ochiai K, Aw TC, Sabaratnam S, Hebbar S, Sickan J, Schodin BA, et
al: Distinguishing benign from malignant pelvic mass utilizing an
algorithm with HE4, menopausal status, and ultrasound findings. J
Gynecol Oncol. 26:46–53. 2015. View Article : Google Scholar :
|
|
8
|
Chen WT, Gao X, Han XD, Zheng H, Guo L and
Lu RQ: HE4 as a serum biomarker for ROMA prediction and prognosis
of epithelial ovarian cancer. Asian Pac J Cancer Prev. 15:101–105.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Angioli R, Capriglione S, Aloisi A, Guzzo
F, Luvero D, Miranda A, Damiani P, Montera R, Terranova C and
Plotti F: Can HE4 predict platinum response during first-line
chemotherapy in ovarian cancer? Tumour Biol. 35:7009–7015. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vallius T, Hynninen J, Auranen A, Carpén
O, Matomäki J, Oksa S, Virtanen J and Grénman S: Serum HE4 and
CA125 as predictors of response and outcome during neoadjuvant
chemotherapy of advanced high-grade serous ovarian cancer. Tumour
Biol. 35:12389–12395. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu LC, Gao J, Hu ZH, Schwab CL, Zhuang
HY, Tan MZ, Yan LM, Liu JJ, Zhang DY and Lin B: Membranous
expressions of Lewis y and CAM-DR-related markers are independent
factors of chemotherapy resistance and poor prognosis in epithelial
ovarian cancer. Am J Cancer Res. 5:830–843. 2015.PubMed/NCBI
|
|
12
|
Kemik P, Saatli B, Yıldırım N, Kemik VD,
Deveci B, Terek MC, Koçtürk S, Koyuncuoğlu M and Saygılı U:
Diagnostic and prognostic values of preoperative serum levels of
YKL-40, HE-4 and DKK-3 in endometrial cancer. Gynecol Oncol.
140:64–69. 2016. View Article : Google Scholar
|
|
13
|
Li X, Gao Y, Tan M, Zhuang H, Gao J, Hu Z,
Wang H, Zhu L, Liu J and Lin B: Expression of HE4 in endometrial
cancer and its clinical significance. Biomed Res Int.
2015:4374682015.PubMed/NCBI
|
|
14
|
Jiang Y, Wang C, Lv B, Ma G and Wang L:
Expression level of serum human epididymis 4 and its prognostic
significance in human non-small cell lung cancer. Int J Clin Exp
Med. 7:5568–5572. 2014.
|
|
15
|
Huang T, Jiang SW, Qin L, Senkowski C,
Lyle C, Terry K, Brower S, Chen H, Glasgow W, Wei Y, et al:
Expression and diagnostic value of HE4 in pancreatic
adenocarcinoma. Int J Mol Sci. 16:2956–2970. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lan WG, Hao YZ, Xu DH, Wang P, Zhou YL and
Ma LB: Serum human epididymis protein 4 is associated with the
treatment response of concurrent chemoradiotherapy and prognosis in
patients with locally advanced non-small cell lung cancer. Clin
Transl Oncol. 18:375–380. 2016. View Article : Google Scholar
|
|
17
|
Lamy PJ, Plassot C and Pujol JL: Serum
HE4: An independent prognostic factor in non-small cell lung
cancer. PLoS One. 10:e01288362015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lu R, Sun X, Xiao R, Zhou L, Gao X and Guo
L: Human epididymis protein 4 (HE4) plays a key role in ovarian
cancer cell adhesion and motility. Biochem Biophys Res Commun.
419:274–280. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Moore RG, Hill EK, Horan T, Yano N, Kim K,
MacLaughlan S, Lambert-Messerlian G, Tseng YD, Padbury JF, Miller
MC, et al: HE4 (WFDC2) gene overexpression promotes ovarian tumor
growth. Sci Rep. 4:35742014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu L, Zhuang H, Wang H, Tan M, Schwab CL,
Deng L, Gao J, Hao Y, Li X, Gao S, et al: Overexpression of HE4
(human epididymis protein 4) enhances proliferation, invasion and
metastasis of ovarian cancer. Oncotarget. 7:729–744. 2016.
|
|
21
|
Chen Y, Mu X, Wang S, Zhao L, Wu Y, Li J
and Li M: WAP four-disulfide core domain protein 2 mediates the
proliferation of human ovarian cancer cells through the regulation
of growth-and apoptosis-associated genes. Oncol Rep. 29:288–296.
2013.
|
|
22
|
Wang H, Zhu L, Gao J, Hu Z and Lin B:
Promotive role of recombinant HE4 protein in proliferation and
carboplatin resistance in ovarian cancer cells. Oncol Rep.
33:403–412. 2015.
|
|
23
|
Zhuang H, Tan M, Liu J, Hu Z, Liu D, Gao
J, Zhu L and Lin B: Human epididymis protein 4 in association with
Annexin II promotes invasion and metastasis of ovarian cancer
cells. Mol Cancer. 13:2432014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhuang H, Hu Z, Tan M, Zhu L, Liu J, Liu
D, Yan L and Lin B: Overexpression of Lewis y antigen promotes
human epididymis protein 4-mediated invasion and metastasis of
ovarian cancer cells. Biochimie. 105:91–98. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Diaz-Montana JJ and Diaz-Diaz N:
Development and use of the Cytoscape app GFD-Net for measuring
semantic dissimilarity of gene networks. F1000Res.
3:1422014.PubMed/NCBI
|
|
26
|
Tollefsen DM: Heparin cofactor II
modulates the response to vascular injury. Arterioscler Thromb Vasc
Biol. 27:454–460. 2007. View Article : Google Scholar
|
|
27
|
Rau JC, Deans C, Hoffman MR, Thomas DB,
Malcom GT, Zieske AW, Strong JP, Koch GG and Church FC: Heparin
cofactor II in atherosclerotic lesions from the Pathobiological
Determinants of Atherosclerosis in Youth (PDAY) study. Exp Mol
Pathol. 87:178–183. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ikeda Y, Aihara K, Yoshida S, Iwase T,
Tajima S, Izawa-Ishizawa Y, Kihira Y, Ishizawa K, Tomita S,
Tsuchiya K, et al: Heparin cofactor II, a serine protease
inhibitor, promotes angiogenesis via activation of the
AMP-activated protein kinase-endothelial nitric-oxide synthase
signaling pathway. J Biol Chem. 287:34256–34263. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liao WY, Ho CC, Hou HH, Hsu TH, Tsai MF,
Chen KY, Chen HY, Lee YC, Yu CJ, Lee CH, et al: Heparin co-factor
II enhances cell motility and promotes metastasis in non-small cell
lung cancer. J Pathol. 235:50–64. 2015. View Article : Google Scholar
|
|
30
|
Cavalcante MS, Torres-Romero JC, Lobo MD,
Moreno FB, Bezerra LP, Lima DS, Matos JC, Moreira RA and
Monteiro-Moreira AC: A panel of glycoproteins as candidate
biomarkers for early diagnosis and treatment evaluation of B-cell
acute lymphoblastic leukemia. Biomark Res. 4:12016. View Article : Google Scholar :
|
|
31
|
Zhuang H, Gao J, Hu Z, Liu J, Liu D and
Lin B: Co-expression of Lewis y antigen with human epididymis
protein 4 in ovarian epithelial carcinoma. PLoS One. 8:e689942013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li J, Chen H, Mariani A, Chen D, Klatt E,
Podratz K, Drapkin R, Broaddus R, Dowdy S and Jiang SW: HE4 (WFDC2)
promotes tumor growth in endometrial cancer cell lines. Int J Mol
Sci. 14:6026–6043. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lu Q, Chen H, Senkowski C, Wang J, Wang X,
Brower S, Glasgow W, Byck D, Jiang SW and Li J: Recombinant HE4
protein promotes proliferation of pancreatic and endometrial cancer
cell lines. Oncol Rep. 35:163–170. 2016.
|
